gen-tirz tirzepatide People Who Stopped Taking the Weight Loss Drug Regained Nearly Half the Weight They Lost Tirzepatide 15mg – Laboratory Research

They are both classified as GLP-1 drugs due to their ability to mimic the bodys natural glucagon-like peptide-1 hormone

The drug tirzepatide (Mounjaro and Zepbound) is a dual GLP-1 and GIP receptor agonist, making its mechanism distinct from semaglutide (Ozempic and Wegovy) and other competitors, which are strictly GLP-1 agonists

These effects lead to sustainable weight loss over time

UNDERSTANDING SEMAGLUTIDE, OZEMPIC, and WEGOVY Semaglutide is a glucagon-like peptide-1 (GLP-1) agonist medication prescribed under the brand names Ozempic and Wegovy

This can be especially helpful for discussing medication side effects, adjusting treatment plans, or getting second opinions without leaving home